We represented a preclinical biomedical company in an environmental investigation and remediation that has occurred since 1998. We assisted the client in discovering the contamination prior to their purchase of the facility, and worked out a strong indemnity wherein the seller pays for all cost of the clean-up, including attorneys’ fees, but our client retains control of the clean-up.
Remediation for Preclinical Biomedical Company in Land Purchase
You Also May Be Interested In:
Successful representation of Medsurant LLC in appeal to vacate $18.8 million dollar jury verdict in case alleging tortious interference
Successful defense of LPL Financial in $5.8 million FINRA arbitration claim
Successfully argued issue of first impression under the Securities Litigation Uniform Standards Act before the U.S. Court of Appeals for the Sixth Circuit